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Abstract
Objective: Differential gene expression in CD177+ and CD1772 neutrophils was investigated, in order to detect possible
differences in neutrophil function which could be related to the pathogenesis of ANCA-associated Vasculitides (AAV).
Methods: Neutrophils were isolated from healthy controls (HC) with high, negative or bimodal CD177 expression, and
sorted into CD177+ and CD1772 subpopulations. Total RNA was screened for expression of 24,000 probes with Illumina Ref-
8 Beadchips. Genes showing differential expression between CD177+ and CD1772 subsets in microarray analysis were re-
assessed using quantitative-PCR. CD177 expression on neutrophil precursors in bone marrow was analyzed using
quantitative PCR and flowcytometry.
Results: The proportion of CD177+ cells increased during neutrophil maturation in bone marrow. Fold change analysis of
gene expression profile of sorted CD177+ and CD1772 neutrophils resulted in 14 genes with fold change (fc) .3 difference
in expression. Interestingly, 10 of these genes have been reported to change significantly in expression during neutrophil
maturation, and most of these genes were granule protein (GP) coding genes. mRNA expression levels measured by RT-PCR
of a number of these GP, and of PR3 and MPO were higher in the CD1772 neutrophil subset in HC, however, particular
granule protein amounts were comparable between CD177+ and CD1772 neutrophil subsets. AAV patients had higher
amounts of CD177+ neutrophils, but contrary to neutrophils from HC expression of GP-genes was increased, possibly due to
activation.
Conclusion: The neutrophil population can be distinguished by membrane expression of CD177 into subsets that are
different in expression of GP mRNA but not in GP protein production. GP gene expression is also elevated in AAV patients,
which is not explained by skewed distribution of CD177+ and CD1772 subsets but may be associated with neutrophil
activation during on-going inflammation.
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Introduction
Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated
vasculitides (AAV) comprise granulomatosis with polyangiitis
(GPA), microscopic polyangiitis (MPA) and eosinophilic granulo-
matosis with polyangiitis (EGPA), which share a spectrum of
clinical manifestations reflecting necrotizing damage to small- and
medium-sized vessels [1,2]. The pathogenic role of ANCA in AAV
is supported by a large body of in vitro and in vivo evidence, and the
presence of ANCA in the circulation is an important serologic
marker for diagnosis and follow-up of AAV [3,4]. Proteinase 3
(PR3) and myeloperoxidase (MPO), both of which are mainly
stored in primary granules of neutrophils, have been identified as
ANCA antigens [5–7]. Although either specificity can occur with
any AAV phenotype, PR3-ANCA are most frequently detected in
sera of GPA patients [8].
In resting neutrophils, PR3 is mainly contained in azurophilic
granules. However, in many individuals a membrane bound form
of PR3 (mPR3) can also be detected in a subset of neutrophils
making these accessible for ANCA binding. In the general
population, the percentage of mPR3 expressing neutrophils ranges
from 0 to 100% and is genetically determined [9,10]. Within a
given individual, the percentage of mPR3high neutrophils is
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e99671
constant in time and is not affected by neutrophil activation,
disease activity or therapy [9–11].
CD177 is a neutrophil specific, GPI-anchored glycoprotein,
compartmentalized in secondary granules [12]. Concurrent with
mPR3, CD177 also shows differential expression on the neutrophil
surface [13]. It has also been observed that mPR3 co-localizes with
CD177 on the neutrophil membrane, and the subpopulation of
neutrophils expressing CD177 is identical to that expressing mPR3
[14]. Although the mechanism of mPR3-CD177 interaction has
not been clearly demonstrated, CD177 is currently proposed as a
receptor of mPR3 on the neutrophil surface [14,15].
In our previous studies, we have reported that proportions of
both mPR3- and CD177-expressing neutrophils are increased in
AAV patients and a high percentage of mPR3high neutrophils is a
risk factor for relapse in GPA [16–18]. These observations indicate
that two subsets of neutrophils exist based on CD177 expression
and that skewed distribution of these two subpopulations may play
a role in the pathogenesis of AAV, although we showed that
CD177+ and CD1772 neutrophils can be equally activated by
PR3-ANCA [16]. CD177 has been described to be a counter
receptor for platelet endothelial cell adhesion molecule (CD31) on
endothelial cells [19], but not for platelets [20]. Recently it was
reported that there is no correlation between decreased apoptosis
rate of neutrophils in AAV and the proportion of CD177+ cells
[21], and others showed that low expression of neutrophil CD177
was highly associated with clonal myeloid disorders [22]. Because
of the lack of knowledge on the biological function for CD177, we
performed a gene microarray-based study to investigate differenc-
es between CD177+ and CD1772 neutrophils, in order to
investigate whether there is a pathophysiologic background of an




For the Illumina microarray study, total RNA from neutrophils
was isolated from healthy controls (HC) with negative (0%,
CD177neg, n = 3), bimodal (40,70%, CD177bimodal, n = 3) and
high (.70%, CD177high, n = 3) levels of CD177 expression. For
the CD177bimodal donors (n = 3), neutrophils were also sorted into
CD177+ and CD1772 subpopulations. For the Illumina micro-
array study, total RNA was isolated from all of the above-
mentioned populations of neutrophils. Genes showing differential
expression between CD177+ and CD1772 subsets in microarray
were re-assessed with additionally sorted CD177+/2 neutrophils
from healthy CD177bimodal donors (n = 7) using quantitative RT-
PCR.
Whether imbalanced distribution of CD177+ and CD1772
neutrophil subsets in AAV leads to altered expression levels of
these genes was assessed within the total population of neutrophils
from HC (n= 19) and GPA patients (n = 8). Characteristics of
patients and HC are listed in Table 1. A diagnosis of GPA was
based on the Chapel Hill definitions [1]. ANCA specificity was
determined by capture ELISA. Disease severity was quantified
using the Birmingham Vasculitis Activity Score (BVAS). Patients
included in the current study were in remission (BVAS=0) and
were not receiving treatment when blood samples were drawn for
analysis. CRP- and ESR levels were recorded.
All patients and controls gave informed written consent and the
study was approved by the Medical Ethical Committee of the
University Medical Center Groningen. The bone marrow studies
were performed at the Department of Hematology, Rigshospitalet,
University of Copenhagen (Denmark). All samples were obtained
after informed consent had been given, according to guidelines
established by the local ethics committee.
Neutrophil isolation and stimulation
Neutrophils were isolated from heparinized venous blood by
centrifugation on Lymphoprep (Axis-Shield, Oslo, Norway) as
described previously [16]. To avoid activation, cells were kept on
ice and washed with Hanks’ balanced salt solution (HBSS) without
Ca2+/Mg2+ (HBSS2/2; Gibco/Life technologies, Breda, The
Netherlands). Isolated neutrophils were used for cell sorting and
subsequently for RNA isolation or western blotting as described
below, or were stimulated. For this, the cell suspension was
transferred to 6-well-plates and stimulated with 1 mg/ml lipopoly-
saccharide (LPS; Escherichia coli O26:B6, Sigma, St Louis, MO,
USA) or 100 ng/ml phorbol-myristate acetate (PMA; Sigma-
Aldrich, Zwijndrecht, The Netherlands) at 37uC for 4 hours. Cells
incubated with normal medium under the same conditions were
included as control.
Membrane staining and sorting of neutrophils
Isolated neutrophils from healthy volunteers were labeled with a
monoclonal antibody against human CD177 (NB1, MEM166;
Abcam, Cambridge, UK) following manufacturer’s instructions.
After washing steps, CD177+ and CD1772 neutrophils were
sorted and collected in ice-cold RPMI by a MoFlo high-speed cell
sorter (DakoCytomation). Activation of positively and negatively
sorted cells was checked by comparing expression for CD66b
(Becton Dickinson, Breda, The Netherlands, nr.561645), CD62L
(Biolegend, San Diego, CA, nr. 304822) and CD54 (Becton
Dickinson, nr. 555512) by flow cytometry, and no differences were
found between the groups (data not shown). For RNA extraction,
at least 16107 cells of each subset were collected.
RNA isolation and microarray hybridization
Total RNA was isolated from neutrophils using a commercially
available kit followed by a DNase digestion step (Qiagen RNeasy
mini kit and Qiagen RNase free DNase set, respectively, Qiagen
Benelux, The Netherlands). Quality and concentration of RNA
samples was assessed with the Experion Automated Electropho-
resis System (Bio-Rad Laboratories, Hercules, CA, USA). The
RNA samples with quality indicator (RQI) number .7.0 were
used for further analysis on expression arrays.
Starting with 200 ng of RNA, the Ambion Illumina TotalPrep
Amplification Kit was used for anti-sense RNA synthesis,
amplification, and purification, according to the manufacturer’s
protocol (Applied Biosystems/Ambion, USA). Afterwards, 750 ng
of complementary RNA per sample was hybridized to Illumina
HumanRef8 Bead-Chips (HumanRef-8_V3_0_R1_11282963_A;
Illumina, San Diego, CA, USA) and scanned on the Illumina
BeadArray Reader. These microarrays contain 24,000 different
probes representing 16,238 different genes; some genes are
targeted by more than one probe.
Microarray data analysis
The initial analysis of processing was performed in the Illumina
BeadStudio Gene Expression module v3.2. Quantile normaliza-
tion and data analysis was done by GeneSpring package version
10.0.0 (Agilent Technologies, Santa Clara, CA, USA). Please refer
to our Supplementary list with our raw genetic data and accession
numbers for the Genespring database. Only samples were
included that passed quality control filtering, which was based
on the median probe intensity, the correlation with all other
samples and the principal component analysis over the samples.
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The probes were filtered for further analysis with the criterion that
the expression value was present in the upper 75% range of all
entities in all of the samples from at least one of the compared
groups. Differences in gene expression between the compared
groups were considered significant based on a fold change (fc).2.0
in gene expression.
Functional annotation and pathway enrichment of genes was
analyzed using the Kyoto encyclopedia of genes and genome
(KEGG) pathways with the GeneCodis functional annotation web
based tool [23,24].
Quantitative RT-PCR (q-PCR)
RNA was extracted from isolated neutrophils. cDNA was
synthesized from 1.0 mg of total RNA. mRNA expression of
CD177, MPO, PR3, lipocalin-2, defensin a1, defensin a3,
defensin a4, bactericidal/permeability-increasing protein (BPI),
cathepsin G and b-actin, was measured in triplicate by the
Taqman real-time PCR system (ABI Prism 7900HT Sequence
Detection System, Applied Biosystems, Foster City, CA) with
specific Taqman primers/probes (Applied Biosystems). Amplifica-
tion was performed using standard conditions and the amount of
target transcript was presented as relative expression (22DCT) or
fold induction (22DDCT) in comparison to unstimulated controls
after being normalized to the expression of b-actin as an
endogenous reference.
CD177 mRNA and protein expression on stages of
neutrophil differentiation in bone marrow
Isolation of bone marrow (BM) populations representing
successive stages of terminal neutrophil differentiation were
performed on bone marrow samples from healthy volunteers
from Denmark by Mora-Jensen and co-workers as described
previously in detail [25]. These different stages are early
promyelocytes (EPM), late promyelocytes (LPM), myelocytes
(MY), metamyelocytes (MM), band cells (BC), and PMNs. mRNA
expression of CD177 was assessed by real time RT-PCR as
described previously [25], b-actin was used to normalize gene-
expression. Expression of CD177 on the membrane of different
stages was detected with monoclonal anti-CD117 by flow
cytometry.
Measurement of granule proteins by quantitative
Western Blot
Cell pellets were suspended with Cell Lysis Buffer (BIOKE, Cell
Signaling, The Netherlands) supplemented with 10% of a protease
inhibitor cocktail (Sigma-Aldrich). Separation by SDS-PAGE and
subsequent western blotting was performed with specific antibod-
ies against CD177 (MEM166; Abcam, Cambridge, UK), PR3
(PR3.G3, house-made), MPO (4A4, Santa Cruz Biotechnology,
Germany), cathepsin G (#H00001511-B01, Abnova Gmbh,
Germany), BPI (H-130, Santa Cruz Biotechnology, Germany) or
defensin a3 (#MA1-35495, Pierce Biotechnology, Rockford,
USA) together with anti-beta-actin (#A5060, Sigma-Aldrich) as
loading control, followed by detection with IRDye secondary
antibodies (800CW and 680LT, Li-COR bioscience, Germany).
Membranes were scanned and analyzed using an Odyssey IR
scanner using Odyssey imaging software 3.0. The protein of
interest was expressed as percentage related to the integrated
intensity of the loading control.
Statistical analysis
In microarray data analysis, a t-test or ANOVA p-value ,0.05,
which was corrected for multiple testing by the Benjamini-
Hochberg method, was considered significant. Results of quanti-
tative RT-PCR and western blotting were presented as means and
analyzed for statistical differences using Wilcoxon matched pairs
test, Spearman correlation test and Mann-Whitney U-test,
performed with GraphPad Prism 4.03 (GraphPad Software, San
Diego, CA). Two-tailed p values of ,0.05 were considered
significant.
Online Supplemental Material
The supplemental gene list (File S1) describes information of
107 genes with fc.2.0 differences that were significantly different
in single gene expression corrected for multiple testing (p,0.05)




Gene expression of circulating neutrophils from healthy donors
was profiled with Illumina Humanref-8 beadchips. As mentioned
before, 5 groups were analyzed separately for two sets of
comparison, namely analysis of the total neutrophil population
from CD177neg, CD177bimodal and CD177high donors and
comparison between two sorted neutrophil subsets, CD177+ and
CD1772, from CD177bimodal donors. After initial quality control
testing and filtering based on expression levels, one sample from a
CD177neg donor was excluded, and 18,448 probes were subjected
to further analysis for comparison between the groups with total
neutrophil populations differentially expressing CD177 as weel as
15,774 probes screened on sorted neutrophil subsets. Microarray
data were further confirmed for low frequency or absence of non-
granulocytic cells by undetectable levels of lineage-specific genes
highly expressed in T- and B-cells (CD3, CD19), monocytes (M-




Gender (% male) 58 50
Age, median (range) 45 (28–60) 65 (47–79)
CRP (mg/l), median (range) ND ,5 (,5–22)
ESR (mg/l), median (range) ND 16 (2–62)
HC: healthy controls; GPA: Patients with granulomatosis with polyangiitis; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; ND: not determined.
doi:10.1371/journal.pone.0099671.t001
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CSFR), eosinophils (eosinophil peroxidase gene (EPX)) and
erythroid cells (glycophorin-A).
When analyzing differentially expressed genes among
CD177neg, CD177bimodal and CD177high donors of the analyzed
transcripts, 472 gene probes showed an fc.2.0 difference in
expression level between CD177neg and CD177high donors; 565
showed an fc.2.0 expression difference between CD177neg and
CD177bimodal donors; and 284 transcripts displayed an fc.2.0
difference between CD177high and CD177bimodal groups. Among
these gene probes, 17 transcripts were significantly different in
single gene expression corrected for multiple testing (p,0.05,
Supplementary Table 1, File S2). Neutrophils from CD177high and
CD177bimodal donors were more similar in gene expression profile
compared to CD177 neg donors, Therefore, we combined
CD177high and CD177bimodal groups and compared these to
CD177neg donors in differential gene expression. We found 107
genes with fc.2.0 differences that were significantly different in
single gene expression corrected for multiple testing (p,0.05)
between CD177neg and CD177high+bimodal populations. However,
no functional pathways or annotation clusters were significantly
enriched within these gene entities (Supplementary gene list, File S1).
To gain a better overview of gene expression profile of these
neutrophil subsets, fc analysis was also performed. This resulted in
14 genes with fc.3.0 differences in expression between the two
subsets (Supplementary Table 2, File S2). Interestingly, 10 of these
genes have been reported to change significantly in expression
during neutrophil maturation, and most of them were granule
protein (GP) coding genes. Moreover, all 10 genes, displaying up-
or down-regulation in BM-neutrophils compared to early-staged
neutrophil precursors, showed accordingly higher or lower
expression levels in the CD177+ subset as compared to the
CD1772 subset [26]. We speculated that differential expression of
GP-related genes, which also represents different stages in
neutrophil maturation, might be one of the features distinguishing
the CD177 negative subset from the positive subset. Therefore,
expression of 43 GP-related genes was compared between the two
subsets. Strikingly, 35 (81%) genes showed higher expression levels
in CD1772 neutrophils as compared to the CD177+ subset. Genes
with fc.1.5 differences in expression levels are listed in Table 2.
Validation of differential expression of granule proteins
by q-PCR and Western Blot
To further confirm the findings, expression of some GP-genes
was measured as representative examples by q-PCR. Since the
sensitivity of microarray chips is considered lower than q-PCR,
mRNA levels of PR3, MPO or CD177 were absent from the list of
detected probes of microarray analysis, which have, however, been
reported to be detected at low levels by q-PCR in healthy persons
in other studies [27,28]. Therefore, as important granule protein
genes in AAV, expression of PR3, MPO and CD177 mRNA was
also measured by q-PCR. In summary, we analyzed gene
expression of 8 granule proteins, most of them stored in
azurophilic or specific granules, including CD177, MPO, PR3,
defensin a1, a3, and a4, cathepsin G, BPI and lipocalin-2 by q-
PCR. Expression of b-actin was tested as endogenous reference.
Confirming proper sorting, CD177-mRNA was low/absent from
CD1772 neutrophils, but expressed at a significantly higher level
in the CD177+ subset. Results showed that cathepsin-G mRNA
was undetectable and MPO expression was low and showed no
difference between the two subsets. All the other granule proteins,
PR3, defensin a1, a3 and a4, BPI and lipocalin-2, showed a
significantly higher mRNA level in CD1772 neutrophils than in
CD177+ cells (Figure 1). In the total neutrophil population (n= 19),
isolated from healthy donors with different levels of CD177
expression, the percentage of CD177+ neutrophils negatively
correlated with the mRNA level of BPI (r =20.6658, p = 0.0027)
and defensin a4 (r =20.4780, p = 0.0384), and showed similar
trends of negative correlation with all the other tested GP-genes.
In contrast but expected, levels of CD177-mRNA in the total
population of neutrophils positively correlated with the propor-
tions of CD177+ neutrophils (r = 0.6257, p= 0.0042).
To assess the differentially expressed GP-related genes at the
protein level, we compared the amounts of granule proteins
between CD177+ and CD1772 neutrophil subsets from 5 different
donors by quantitative Western Blot. CD177 protein (NB1) was
absent in the lysates of membrane-bound CD177 (mCD177)
negative neutrophils, but present in the positives. The amounts of
GPs, taking PR3, cathepsin G, defensin a3, MPO and BPI as
Table 2. GP-related genes with fold change.1.5 up-regulated expression in the sorted CD1772 neutrophil subset as compared to
the CD177+ subset.
Gene symbol FC Synonym Definition
DEFA4 8.81 HNP-4; HP4; HP-4; DEF4 Defensin, alpha 4, corticostatin.
DEFA3 6.74 HNP3; HNP-3; DEF3; HP-3 Defensin, alpha 3, neutrophil-specific.
DEFA1 6.35 DEF1; DEFA2; HP-1; HNP-1 Defensin, alpha 1.
CEACAM8 4.65 NCA-95; CGM6; CD67; CD66b Carcinoembryonic antigen-related cell adhesion molecule 8.
LCN2 3.24 NGAL Lipocalin 2.
CTSG 2.67 MGC23078; CG Cathepsin G.
BPI 2.30 Bactericidal/permeability-increasing protein.
TCN1 2.11 TCI; TC1 Transcobalamin I (vitamin B12 binding protein, R binder family).
NCF1 1.77 NOXO2; SH3PXD1A; p47phox; NCF1A Neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)
S100PBP 1.71 DKFZp313K2325; FLJ12903; S100PBPR S100P binding protein, transcript variant 2.
CRISP3 1.69 MGC126588; SGP28; Aeg2; CRS3; CRISP-3; dJ442L6.3 Cysteine-rich secretory protein 3.
ELA2 1.68 HLE; GE; PMN-E; NE; HNE Elastase 2, neutrophil.
RPL10A 1.66 Csa-19; NEDD6 Ribosomal protein L10a.
LTF 1.54 HLF2; GIG12 Lactotransferrin.
doi:10.1371/journal.pone.0099671.t002
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representatives, were comparable between the two neutrophil
subsets (Figure 2).
Membrane CD177 expression emerges gradually during
neutrophil differentiation
As shown before, GP-related genes, which are supposed to be
actively expressed in neutrophil precursors but remarkably down-
regulated in mature neutrophils [23], were significantly increased
in CD1772 neutrophils in a healthy population, suggesting a link
between lack of CD177 expression and immature neutrophils.
Therefore, CD177 expression was measured during terminal
neutrophil differentiation both at the mRNA and the protein level.
In figure 3A results of CD177 mRNA levels of 4 different BM
donors is shown. Expression of CD177 increased during differen-
tiation and peaked in band cells. CD177 protein expression
measured by FACS became evident on stages differentiated to
(meta)myelocytes and further. In figure 3B a representative picture
is shown from a donor who had 49% CD177 positive mature
neutrophils.
Increased GP gene expression in AAV
As mentioned before, percentages of CD177+ neutrophils are
elevated in patients with AAV. This subset shows lower
transcription of GP genes than the CD1772 subset. It is, therefore,
reasonable to assume that circulating neutrophils from AAV
patients show a decreased expression of GP genes compared to
HC. Total neutrophils were isolated from the peripheral blood of 8
patients with quiescent AAV and 19 healthy donors. Expression of
CD177, MPO, PR3, defensin a1, a3, and a4, cathepsin G, BPI
and lipocalin-2 was tested and compared between AAV patients
and HC. Whereas most of these genes showed comparable or
slightly higher levels of GP gene expression compared to HC,
CD177-, DEFA3- and MPO- mRNA showed significantly
increased expression levels in AAV patients (Figure 4A).
Elevated levels of circulating proinflammatory cytokines have
been reported in patients with AAV, which may cause in vivo
activation of neutrophils [29]. Whether GP gene expression in
AAV is influenced by neutrophil activation was subsequently
investigated. Neutrophils from three CD177high HC, three
Figure 1. Expression of mRNA levels of graule proteins measured by taqman RT-PCR. Expression levels of mRNA of on left Y-axis defensin
a1, defensin a3 (DEFA1, 3), and on right y-axis CD177, PR3 (PRTN3), and defensin a4 (DEFA4), BPI, and lipocalin 2 (LCN2) were measured by q-PCR.
Expression levels of GP-related genes in CD177+ and CD1772 subsets sorted from healthy donors (n = 7) are depicted. *, P,0.05.
doi:10.1371/journal.pone.0099671.g001
Figure 2. Expression of granule proteins measured by quantitative Western Blot. Expression of CD177, PR3, MPO, defensin a3, BPI and
cathepsin G in CD177+ and CD1772 subsets sorted from healthy donors (n = 5) was measured and quantified by Western Blot (Odyssey). Expression of
b-actin was included as loading control for each sample. Results of 5 donors are presented as relative expression, that is percentage as compared to
the signal intensity of the loading control.
doi:10.1371/journal.pone.0099671.g002
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Figure 3. CD177 expression during terminal neutrophil differentiation. BM populations representing successive stages of neutrophil
differentiation were isolated from healthy donors by lymphoprep centrifugation followed by immunomagnetic depletion of non-granolocytic cells
(MACS) and flow cytometry-based cell sorting. In short, BM was obtained from healthy controls, depleted of erythrocytes and subjected to one-layer
density gradient centrifugation using Lymphoprep. The resultant interphase exists of mononuclear cells (MNCs), containing hematopietic stem/
progenitor cells and mature cells of all hematopoietic lineages, and the cell pellet contains primarily PMNs and band cells (BCs). Non-granulocytic
cells were depleted using a cocktail of biotinylated mAbs followed by incubation with anti-biotin antibody, conjugated with magnetic beads, and run
on MACS separation columns (Miltenyi, Bergisch Gladbach, Germany). The resultant lineage-depleted cells are stained with a cocktail of
fluorochrome-conjugated MoAbs and streptavidin-PE-Cy5. Addition of streptavidin-PE-Cy5 stains residual non-granulocytic cells that are labeled by
biotinylated lineage-specific MoAbs, which allows for additional depletion of non-granulocytic cells during cell sorting. After staining cells were
washed and resuspended in PBS/3%FCS containing the DNA dye 7AAD, which allows for sorting of viable non-apoptotic cells (i.e. 7AAD negative
cells). Subsequently, the six BM populations representing the successive stages of terminal neutrophil differentiation were sorted using the FACSAria
Two Subsets of Neutrophils in ANCA-Associated Vasculitis
PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e99671
CD177neg HC and 3 AAV patients were ex vivo stimulated with
PMA or LPS for 4 hours and total RNA was extracted for RT-
PCR. Expression of CD177-mRNA was not influenced during
activation in all groups compared to unstimulated cells, while
transcription of MPO, PR3, lipocalin2, cathepsin G, defensins,
and BPI was induced in particular by PMA stimulation. There
were no significant differences between the groups at baseline,
except for CD177 negative versus CD177 high and between
CD177 negative versus AAV (Figure 4B).
Discussion
In this microarray-based study, we investigated differences in
gene expression profile between neutrophils from donors with
varying levels of mCD177 and between CD177+ and CD1772
neutrophil subsets from single individuals, in order to investigate
the pathophysiologic significance of an increased CD177+/
mPR3high neutrophil subset for the pathogenesis of AAV.
Based on the data from this microarray analysis neutrophils
from donors positive in mCD177 expression, are likely to share a
comparable expression profile, but they are different from
neutrophils of CD177 negative donors. However, by KEGG
pathway analysis, no pathways or annotations of biological
functions were significantly enriched when analyzing the genes
differentially expressed between donors with and without CD177-
expressing neutrophils. Granule protein (GP)-related genes, at the
mRNA level, were expressed at higher levels in the CD1772
neutrophil subset than in the CD177+ subset, the underlying
mechanism of which is not clear but may be related to the
maturation state of neutrophils. Patients with AAV also displayed
increased expression of GP-related genes in their neutrophils,
which does not correspond with their higher percentage of
CD177+ neutrophils compared to HC. On-going inflammation in
AAV might explain this observation, since mRNA expression of
these GP-related genes could be induced during neutrophil
activation.
Mechanisms underlying differential expression of CD177 on
neutrophils are not fully understood. Polymorphisms in DNA
sequence of CD177, that is, C34G, A778C and G1069A, or
methylation in the CpG islands close to the promoter region have
been suggested to be associated with a low percentage of CD177+
neutrophils in donors with bimodal expression of CD177
[28,30,31]. It is known that neutrophil CD177 expression can
increase significantly in certain clinical conditions, such as severe
bacterial infections and polycythemia vera [32]. Also a significant
increased CD177 expression was found in neutrophils from
newborns compared to adults, suggesting the existence of
additional factors being able to stimulate CD177 expression
[33]. Total CD177-deficiency in healthy donors is probably due to
an abnormal insertion containing stop codon in the CD177gene
[28,34]. Donors without CD177 expression also displayed
different properties compared to CD177-expressing donors in
our microarray analysis, which showed 107 gene probes differen-
tially expressed between total neutrophils from CD177-positive
donors and donors with CD177 deficiency. However, these genes
were described to be associated with various biological functions
and no specific biological processes were indicated by the pathway
analysis performed with KEGG pathways or GeneCodis func-
tional annotation web-based tool. Besides, no studies have
demonstrated abnormal neutrophil function in CD177-deficient
healthy donors.
When analyzing the differences between the CD177+ and
CD1772 neutrophil subsets, GP-related genes showed higher
expression levels in the CD1772 subset than in CD177+
neutrophils from the same individual. As a result, GP gene
expression negatively correlated with the proportion of CD177-
expressing neutrophils in a healthy population. These GP genes
are variably expressed during neutrophil differentiation in the
bone marrow and highly expressed in neutrophil precursors
compared to mature neutrophils [26].
Although circulating immature neutrophils are rarely seen in
the normal situation, enriched expression of GP-related genes in
both immature neutrophils and the CD1772 subset suggests a
relationship between CD1772 and immature neutrophils. FACS
analysis supported this assumption and revealed gradual emer-
gence of CD177 on the membrane of neutrophils during
maturation in the bone marrow. CD177 protein expression
measured by FACS became evident on stages differentiated to
metamyelocytes and further. These data corroborate the data of
Stroncek et al, who investigated CD177 expression on fetal bone
marrow samples [35] and also those of Meyerson et al, who
showed that the most mature neutrophils, expressing CD16 and
CD11b also had the highest CD177 expression [22]. Mora-Jensen
et al used the same method for isolating neutrophil stages from the
bone marrow and investigated the expression of proteins
representing the different granules [25]. CD177 expression seems
to have the same pattern as MMP-9 which is a tertiary granule
protein. When migrated into the blood, these immature neutro-
phils will be more enriched in the CD1772 subset than in the
CD177+ neutrophil subset, which, to some extent, also explains
higher levels of GP gene expression in CD1772 neutrophils. Cell
functions are mostly dependent on proteins stored or produced
within the cell. Although mRNA of GP-related genes was higher
expressed in CD1772 neutrophils, the amounts of granule
proteins, except for CD177, were not significantly different
between the two subsets. It has indeed been reported that changes
in granule proteins and mRNA expression are not always
identical, especially for the early produced proteins during
neutrophil maturation, such as proteins stored in azurophilic
granules, which are synthesized transiently at the promyelocyte or
metamyelocyte stages, and remain stored in granules throughout
the terminal granulocytic differentiation [26]. However, not all of
the genes showing differential expression between CD177+ and
CD1772 neutrophils were assessed for expression at the protein
level. As the major differences between CD177+ and CD1772
neutrophils were related to GP genes we chose to restrict our
analysis at the protein level to granule proteins.
As mentioned, CD177 mRNA expression increased during
differentiation of neutrophils, while PR3 and MPO, granule
proteins stored in azurophilic granules, had highest mRNA
expression in promyelocytes. mRNA expression is absent in
mature neutrophils and there is no de novo synthesis of protein in
mature neutrophils [26]. So, mRNA expression of CD177 and
PR3 is differentially regulated during differentiation of neutrophils.
In 2007 von Vietinghoff et al showed that membrane expression of
the ANCA antigen PR3 on neutrophils is mediated by CD177
Cell sorter (BD Biosciences, San Jose, CA, USA). (A) mRNA expression of CD177 by quantitative RT-PCR in BM populations from 4 donors was
determined and normalized against b-actin. (B) Representative example of CD177 expression on each BM population was measured by flow
cytometry. Abbreviations: EPM, early promyelocyte; LPM, late promyelocyte: MY, myelocyte; MM, metamyelocytes; BC, band cells; MNC, mononuclear
cells; PMN, polymorphonuclear cells; BM, bone marrow; PB, peripheral blood.
doi:10.1371/journal.pone.0099671.g003
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Figure 4. Expression of GP-related genes in AAV. (A) Expression levels of mRNA of defensin a1, a3 (DEFA1,3, left y-axis), and of CD177, PR3
(PRTN3), MPO, defensin a4 (DEFA4), BPI and lipocalin 2 (LCN2) (right y-axis) were measured by q-PCR. Relative expression of GP-mRNA in the total
neutrophil population was compared between patients with AAV (n = 8) and healthy donors (n = 19). Horizontal lines denote the median. *, P,0.05;
**, P,0.01. (B) Isolated neutrophils of three CD177 negative donors, three CD177 high donors, and three AAV patients were stimulated with PMA or
LPS for 4 hours. Total RNA was extracted and quantified for GP gene expression by RT-PCR. Results are presented as relative expression relative to b-
actin. White bars are unstimulated samples, grey bars are PMA stimulated samples, dark grey bars are LPS-stimulated samples.
doi:10.1371/journal.pone.0099671.g004
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[14]. Abdgawad et al investigated co-expression of mPR3 and
CD177 on neutrophils and found that all neutrophils in a given
individual were either double-positive or double-negative for PR3
and CD177 [36]. The proportion of double-positive cells was
significantly increased in AAV and SLE patients, as our group
previously also reported [16]. They further demonstrated
increased mRNA levels of both PR3 and CD177 in AAV patients
(as shown also in figure 4A), but these levels did not correlate with
the proportion of double-positive cells. Furthermore, they showed
that when exogenous PR3 was added to CD177 transfected cells,
only CD177pos cells bound PR3 to their membrane. Based on
these data, the authors concluded that the increased membrane
expression of PR3 in AAV is dependent on CD177 expression and
correlates with transcription of the CD177 gene [36].
Further considering AAV, patients showing an expanded subset
of CD177+ neutrophils could supposedly have decreased levels of
GP gene expression, as based on the findings in healthy donors.
However, our cohort of patients with quiescent AAV showed,
increased expression of GP genes, and defensin a4 and MPO
expression was significantly higher in these patients compared to
controls. This is in line with an earlier study by Yang et al. in
which the authors observed significantly increased expression of
GP genes in neutrophils from AAV patients, which correlated with
disease activity and absolute neutrophil number [37]. It has been
suggested that low levels of immune activation exist in AAV
patients even in remission [38]. Some of our patients, being in
clinical remission, indeed, showed increased levels of CRP and
ESR. PMA and LPS induced upregulated expression of these GP
genes, suggesting that GP-gene expression is not stable but can be
modulated by external stimuli during neutrophil activation.
Therefore, on-going inflammation in AAV patients may be
responsible for GP gene activation, supported by further increased
expression of GP-genes as observed in active AAV patients
compared to patients in remission [27,37]. Whether these
overproduced GP-genes are translated into proteins and partici-
pate in pathophysiological functions of neutrophils in AAV
deserves further investigation.
In summary, the neutrophil population is not homogeneous and
can be distinguished by membrane expression of CD177 into
subsets which are different in expression of GP-related genes. GP
gene expression is also elevated in AAV patients, which is not
explained by skewed distribution of CD177+ and CD1772 subsets,
but may be associated with neutrophil activation during on-going
inflammation.
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